SC 13D
SC 13D Filing
- Company
- Emmaus Life Sciences, Inc.
- Filed
- January 31, 2007
- Accession Number
- 0001077048-07-000044
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →